Marketing-authorisation holder · United States
Torrent
19 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
19 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
19 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| EZETIMIBE AND SIMVASTATIN10mg; 10mg | 10mg; 20mg | 10mg; 40mg | 10mg; 80mg · Tablet | Ezetimibe, Simvastatin | United States | Marketed | 2017 |
| IBUPROFEN AND FAMOTIDINE26.6mg; 800mg · Tablet | Famotidine, Ibuprofen | United States | Marketed | 2021 |
| ISOSORBIDE MONONITRATE120mg | 30mg | 60mg · Tablet, extended release | Isosorbide mononitrate | United States | Marketed | 1998 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE12.5mg; 100mg | 12.5mg; 50mg | 25mg; 100mg · Tablet | Hydrochlorothiazide, Losartan | United States | Marketed | 2010 |
| MINOCYCLINE HYDROCHLORIDE100MG BASE | 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG BASE | 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 75MG BASE · Tablet | Minocycline | United States | Marketed | 1982 |
| MONTELUKAST SODIUM10mg base · Tablet | Montelukast | United States | Marketed | 2012 |
| NILOTINIB HYDROCHLORIDE150mg base | 200mg base | 50mg base · Capsule | Nilotinib | United States | Marketed | 2024 |
| OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE10mg base; 12.5mg; 40mg | 10mg base; 25mg; 40mg | 5mg base; 12.5mg; 20mg | 5mg base; 12.5mg; 40mg | 5mg base; 25mg; 40mg · Tablet | Amlodipine, Hydrochlorothiazide, Olmesartan medoxomilo | United States | Marketed | 2016 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5mg; 20mg | 12.5mg; 40mg | 25mg; 40mg · Tablet | Hydrochlorothiazide, Olmesartan medoxomilo | United States | Marketed | 2016 |
| ORMALVI50mg · Tablet | Dichlorphenamide | United States | Marketed | 2022 |
| RABEPRAZOLE SODIUM20mg · Tablet, delayed release | Rabeprazole | United States | Marketed | 2013 |
| SACUBITRIL AND VALSARTAN24mg; 26mg | 49mg; 51mg | 97mg; 103mg · Tablet | Sacubitril, Valsartan | United States | Marketed | 2024 |
| SEVELAMER CARBONATE2.4gm/packet | 800mg/packet · For suspension | Sevelamer | United States | Marketed | 2017 |
| TELMISARTAN AND AMLODIPINE10mg base; 40mg | 10mg base; 80mg | 5mg base; 40mg | 5mg base; 80mg · Tablet | Amlodipine, Telmisartan | United States | Marketed | 2014 |
| VENXXIVA100mg | 300mg · Tablet, delayed release | Tiopronin | United States | Marketed | 2024 |
| ALOGLIPTIN; METFORMIN HYDROCHLORIDE12.5mg base; 1gm | 12.5mg base; 500mg · Tablet | Alogliptin, Metformin | United States | tentative | 2018 |
| NILOTINIB200mg · Capsule | Nilotinib | United States | tentative | 2025 |
| RUXOLITINIB10mg | 15mg | 20mg | 5mg · Tablet | Ruxolitinib | United States | tentative | 2026 |
| VALSARTAN; HYDROCHLOROTHIAZIDE160mg; 12.5mg | 160mg; 25mg | 320mg; 12.5mg | 320mg; 25mg | 80mg; 12.5mg · Tablet | Valsartan, Hydrochlorothiazide | United States | tentative | 2012 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 19 | 15 | 4 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.